Promises and challenges in up-and-coming CLL therapies

Promises and challenges in up-and-coming CLL therapies

VJHemOnc

1 year
201 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Promising novel therapies are on the horizon within the field of chronic lymphocytic leukemia (CLL). Here, Jennifer Woyach, MD, of the Ohio State University Comprehensive Cancer Center, Columbus, OH, discusses an exciting array of therapeutics which are being utilized in clinical practice: BTK, PI3K and BCL-2 inhibitors. In addition, Dr Woyach explores the use of immunotherapy ventures, such as CAR T cells, speculating upon the efficacy surrounding combination treatments. Moreover, she explores the possibility of utilizing up-and-coming therapeutics, which are currently in early clinical trials, such as reversable BTK inhibitors and bromodomain inhibitors. Dr Woyach finally touches upon some challenges faced within the field, namely patient discontinuation of ibrutinib and venetoclax, when patients should be referred for bone marrow transplant, and the role of Richter transformation in relapse. This video was recorded at the British Society for Haematology (BSH) 2018 Annual Meeting, in Liverpool, UK.
Up Next Autoplay
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
200 Views
cancergrace 4 months
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
Category: Chronic Lymphocytic Leukemia
91 Views
cancergrace 4 months
CLL, What is the significance of IGHV mutations and how are they assessed
CLL, What is the significance of IGHV mutations and how are they assessed
Category: Chronic Lymphocytic Leukemia
86 Views
cancergrace 4 months
Not Your Fathers CLL with Dr. John Pagel
Not Your Fathers CLL with Dr. John Pagel
Category: Chronic Lymphocytic Leukemia
113 Views
cancergrace 4 months
CLL, Is there a role still for chemo AND who should get chemo
CLL, Is there a role still for chemo AND who should get chemo
Category: Chronic Lymphocytic Leukemia
74 Views
cancergrace 4 months
CLL, FCR vs BR – Is One Better
CLL, FCR vs BR – Is One Better
Category: Chronic Lymphocytic Leukemia
176 Views
cancergrace 4 months
The Role of CAR-T Therapy in B-Cell Lymphomas
The Role of CAR-T Therapy in B-Cell Lymphomas
Category: Chronic Lymphocytic Leukemia
69 Views
obr 4 months
Outcomes from RESONATE Trial in Relapsed CLL
Outcomes from RESONATE Trial in Relapsed CLL
Category: Chronic Lymphocytic Leukemia
68 Views
obr 4 months
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
149 Views
obr 4 months
Opinion on Ibrutinib on 1st Line CLL
Opinion on Ibrutinib on 1st Line CLL
Category: Chronic Lymphocytic Leukemia
196 Views
obr 4 months